TrialAmerican journal of respiratory and critical care medicine2018

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.

Gustavo E Velásquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.